Skip to content

Hoth Therapeutics, Inc.

HOTH RKTO

CIK 0001711786

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$12.47M
−52.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.91
+29.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$9.86M
Q1 May 2026
Cash
$4.05M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
19.13M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings